Back to
Temasek Holdings (Private) Ltd
DNLI
Showing 9 of 32 quarters
Position history for
Temasek Holdings (Private) Ltd's holdings in Denali Therapeutics Inc.
Yes. Temasek Holdings (Private) holds 7,012,974 shares of DNLI (Denali Therapeutics), worth $145M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Temasek Holdings (Private) has held DNLI in every 13F on record since Q4 2018, 32 quarterly filings. DNLI is 0.4% of Temasek Holdings (Private)'s reported 13F portfolio.
Current Value
$145M
Current Shares
7M
Total Value Change
-$11.1M
Total Shares Change
+1.7M
Quarter-by-Quarter History